...
机译:沙美特罗/氟替卡松联合治疗对儿童哮喘患者的氟替卡松剂量加倍
Department of Pediatrics, Amphia Hospital, Langendijk 75, 4819 EV Breda, the Netherlands;
Department of Pediatrics, Flevo Hospital, Almere, the Netherlands;
Department of Pediatric Respiratory Diseases, Academic Medical Center/Emma's Children's Hospital, Amsterdam, the Netherlands;
Department of Pediatrics, Catharina Hospital, Eindhoven, the Netherlands;
Department of Pediatrics, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands;
Department of Biostatistics, Erasmus University Medical Center, Rotterdam, the Netherlands;
Department of Pediatric Respiratory Diseases,University Medical Center Groningen/Beatrix Children's Hospital, Groningen, the Netherlands;
asthma; child; inhaled corticosteroid; long-acting (3_2-agonist;
机译:在最近开始联合治疗的哮喘患者中,逐步使用丙酸氟替卡松或较低剂量的丙酸氟替卡松/沙美特罗组合。
机译:在哮喘患者中,单用吸入剂沙美特罗/丙酸氟替卡松联合治疗与增加吸入皮质类固醇的剂量。
机译:添加沙美特罗与加倍丙酸氟替卡松的剂量对哮喘儿童特定气道阻力的影响。
机译:使用LC / MS / MS从等离子体中低水平定量氟酮和唾液测定醇
机译:在一项随机对照试验中比较曲安奈德(Azmacort HFA)和丙酸氟替卡松(Flovent)在成年哮喘患者中的成本-效果比较
机译:哮喘治疗:糠酸莫米松/福莫特罗与丙酸氟替卡松/沙美特罗联合治疗对持续性哮喘患者的疗效比较188:非劣效性和开始行动的结果
机译:中剂量茚钒/甘油酮/米多酮呋喃固定剂组合改善了肺功能与高剂量茚钒/米多酮呋喃(Salmeterol / Fluticason)相比,并降低了中度至严重的哮喘中的高剂量Salmeterol /氟替卡松的恶化率:铱学习